Optimizing animal models for HIV-associated CNS dysfunction and CNS reservoir research

J Neurovirol. 2018 Apr;24(2):137-140. doi: 10.1007/s13365-018-0631-7. Epub 2018 Mar 26.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • AIDS Dementia Complex / drug therapy
  • AIDS Dementia Complex / immunology
  • AIDS Dementia Complex / physiopathology
  • AIDS Dementia Complex / virology*
  • Animals
  • Antiviral Agents / pharmacology
  • Cats
  • Central Nervous System / virology*
  • Cognitive Dysfunction / drug therapy
  • Cognitive Dysfunction / immunology
  • Cognitive Dysfunction / physiopathology
  • Cognitive Dysfunction / virology*
  • Disease Models, Animal*
  • Feline Acquired Immunodeficiency Syndrome / drug therapy
  • Feline Acquired Immunodeficiency Syndrome / immunology
  • Feline Acquired Immunodeficiency Syndrome / physiopathology
  • Feline Acquired Immunodeficiency Syndrome / virology
  • HIV-1 / drug effects
  • HIV-1 / pathogenicity
  • HIV-1 / physiology*
  • Humans
  • Immunodeficiency Virus, Feline / drug effects
  • Immunodeficiency Virus, Feline / pathogenicity
  • Immunodeficiency Virus, Feline / physiology
  • Macaca
  • Mice
  • Rats
  • Simian Acquired Immunodeficiency Syndrome / drug therapy
  • Simian Acquired Immunodeficiency Syndrome / immunology
  • Simian Acquired Immunodeficiency Syndrome / physiopathology
  • Simian Acquired Immunodeficiency Syndrome / virology
  • Simian Immunodeficiency Virus / drug effects
  • Simian Immunodeficiency Virus / pathogenicity
  • Simian Immunodeficiency Virus / physiology
  • Virus Latency / drug effects
  • Virus Latency / physiology

Substances

  • Antiviral Agents